Catalyst Pharmaceutical Partners Inc buy Stephens
Start price
27.02.25
/
50%
€22.13
Target price
27.02.26
€31.66
Performance (%)
-12.22%
End price
28.02.26
€19.43
Summary
This prediction ended on 28.02.26 with a price of €19.43. The prediction for Catalyst Pharmaceutical Partners Inc disappointed with a performance of -12.22%. Stephens has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Catalyst Pharmaceutical Partners Inc | 0.712% | 0.712% | 1.775% |
| iShares Core DAX® | -3,81 % | -1,47 % | 6,06 % |
| iShares Nasdaq 100 | 0,49 % | 2,21 % | 12,68 % |
| iShares Nikkei 225® | -4,42 % | 4,97 % | 30,91 % |
| iShares S&P 500 | 0,25 % | 1,23 % | 9,37 % |
Comments by Stephens for this prediction
In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $33.00 price target on the stock.
Ratings data for CPRX provided by MarketBeat
In the thread Trading Catalyst Pharmaceutical Partners Inc
Die von Stephens gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Stephens for Catalyst Pharmaceutical Partners Inc
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€19.62
18.11.24
18.11.24
€33.11
18.11.25
18.11.25
-1.83%
19.11.25
19.11.25
